Anti-angiogenic therapy inhibits tumor growth effectively by reducing vessel density; however, the subsequent expression of hypoxia-inducible factors (HIFs) and the responsive genes (for example,VEGF,VEGFR,carbonic anhydrase [CA]IX, andCAXII) can lead to therapeutic resistance8. This evidence concerns the gene VEGFA and neoplasm.